Compare ELV & AME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELV | AME |
|---|---|---|
| Founded | 1944 | 1930 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.6B | 58.2B |
| IPO Year | 2001 | 1998 |
| Metric | ELV | AME |
|---|---|---|
| Price | $402.63 | $242.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 12 |
| Target Price | ★ $383.56 | $233.27 |
| AVG Volume (30 Days) | 949.5K | ★ 1.2M |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.83% | 0.60% |
| EPS Growth | N/A | ★ 7.93 |
| EPS | ★ 14.73 | 3.51 |
| Revenue | ★ $199,125,000,000.00 | $7,401,116,000.00 |
| Revenue This Year | N/A | $8.86 |
| Revenue Next Year | $3.07 | $5.57 |
| P/E Ratio | ★ $27.19 | $68.25 |
| Revenue Growth | ★ 12.49 | 6.63 |
| 52 Week Low | $274.89 | $179.30 |
| 52 Week High | $436.24 | $261.16 |
| Indicator | ELV | AME |
|---|---|---|
| Relative Strength Index (RSI) | 56.27 | 45.33 |
| Support Level | $382.77 | $222.93 |
| Resistance Level | $406.36 | $261.16 |
| Average True Range (ATR) | 9.68 | 4.89 |
| MACD | 1.45 | -2.08 |
| Stochastic Oscillator | 87.01 | 18.83 |
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns more than 40 autonomous industrial businesses operating across research, aerospace, energy, medical, and manufacturing. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets it operates in.